The Kroger Co. (NYSE: KR) has officially concluded the sale of its specialty pharmacy business to Elevance Health, as initially announced in a definitive agreement on March 18, 2024. According to Kroger, the primary objective of this sale was to ensure minimal disruption for both patients and employees, as the company strategically refines its portfolio […]
The Kroger Co. (NYSE: KR) has announced a definitive agreement for the sale of its specialty pharmacy business to CarelonRx, a subsidiary of Elevance Health, marking a significant transaction in the healthcare industry. The deal is poised to reshape Kroger’s involvement in specialty pharmacy services, underscoring the company’s strategic evaluation of its assets to enhance […]
